메뉴 건너뛰기




Volumn 163, Issue 6, 2012, Pages

Design and rationale of a retrospective clinical effectiveness study of aldosterone antagonist therapy in patients with heart failure

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; WARFARIN;

EID: 84862571101     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.03.007     Document Type: Article
Times cited : (4)

References (24)
  • 1
    • 60449094498 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-e181.
    • (2009) Circulation , vol.119
    • Lloyd-Jones, D.1    Adams, R.2    Carnethon, M.3
  • 2
    • 84862566790 scopus 로고    scopus 로고
    • 2010 Edition. Last accessed May 12, 2011
    • Centers for Medicare & Medicaid Services. Medicare & Medicaid Statistical Supplement, 2010 Edition. http://www.cms.gov/ MedicareMedicaidStatSupp/09-2010.asp. Last accessed May 12, 2011.
    • Medicare & Medicaid Statistical Supplement
  • 3
    • 58149098405 scopus 로고    scopus 로고
    • Early and long-term outcomes of heart failure in elderly persons, 2001-2005
    • Curtis LH, Greiner MA, Hammill BG, et al. Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med 2008;168:2481-8.
    • (2008) Arch Intern Med , vol.168 , pp. 2481-2488
    • Curtis, L.H.1    Greiner, M.A.2    Hammill, B.G.3
  • 4
    • 79955162230 scopus 로고    scopus 로고
    • The persistent exclusion of older patients from ongoing clinical trials regarding heart failure
    • Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med 2011;171:550-6.
    • (2011) Arch Intern Med , vol.171 , pp. 550-556
    • Cherubini, A.1    Oristrell, J.2    Pla, X.3
  • 5
    • 24044466543 scopus 로고    scopus 로고
    • The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure
    • DOI 10.1016/j.jacc.2005.06.010, PII S0735109705013173
    • Shah KB, Rao K, Sawyer R, et al. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. J Am Coll Cardiol 2005;46:845-9. (Pubitemid 41224809)
    • (2005) Journal of the American College of Cardiology , vol.46 , Issue.5 , pp. 845-849
    • Shah, K.B.1    Rao, K.2    Sawyer, R.3    Gottlieb, S.S.4
  • 7
    • 24944563849 scopus 로고    scopus 로고
    • ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure).
    • Hunt SA; American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1-e82.
    • (2005) J Am Coll Cardiol , vol.46
    • Hunt, S.A.1
  • 8
    • 70350733579 scopus 로고    scopus 로고
    • Use of aldosterone antagonists in heart failure
    • Albert NM, Yancy CW, Liang L, et al. Use of aldosterone antagonists in heart failure. JAMA 2009;302:1658-65.
    • (2009) JAMA , vol.302 , pp. 1658-1665
    • Albert, N.M.1    Yancy, C.W.2    Liang, L.3
  • 9
    • 55149110356 scopus 로고    scopus 로고
    • Heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF
    • Fonarow GC, Yancy CW, Albert NM, et al. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail 2008;1:98-106.
    • (2008) Circ Heart Fail , vol.1 , pp. 98-106
    • Fonarow, G.C.1    Yancy, C.W.2    Albert, N.M.3
  • 11
    • 79958175843 scopus 로고    scopus 로고
    • Ensuring integrity in comparative effectiveness research: Accentuate the negative
    • Ensuring integrity in comparative effectiveness research: accentuate the negative. PLoS Med 2009;6:e1000152.
    • (2009) PLoS Med , vol.6
  • 13
    • 33845473106 scopus 로고    scopus 로고
    • Overview of the American Heart Association "Get with the guidelines" programs: Coronary heart disease, stroke, and heart failure
    • DOI 10.1097/01.hpc.0000243588.00012.79, PII 0013257720061200000001
    • Hong Y, LaBresh KA. Overview of the American Heart Association "Get with the Guidelines" programs: coronary heart disease, stroke, and heart failure. Crit Pathw Cardiol 2006;5:179-86. (Pubitemid 44912337)
    • (2006) Critical Pathways in Cardiology , vol.5 , Issue.4 , pp. 179-186
    • Hong, Y.1    LaBresh, K.A.2
  • 14
    • 67049159418 scopus 로고    scopus 로고
    • Linking inpatient clinical registry data to Medicare claims data using indirect identifiers
    • Hammill BG, Hernandez AF, Peterson ED, et al. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J 2009;157:995-1000.
    • (2009) Am Heart J , vol.157 , pp. 995-1000
    • Hammill, B.G.1    Hernandez, A.F.2    Peterson, E.D.3
  • 15
    • 0142157169 scopus 로고    scopus 로고
    • Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
    • DOI 10.1093/aje/kwg231
    • Ray WA. Evaluating medication effects outside of clinical trials: newuser designs. Am J Epidemiol 2003;158:915-20. (Pubitemid 37323253)
    • (2003) American Journal of Epidemiology , vol.158 , Issue.9 , pp. 915-920
    • Ray, W.A.1
  • 16
    • 54049122494 scopus 로고    scopus 로고
    • An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure
    • Keenan PS, Normand SL, Lin Z, et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 2008;1:29-37.
    • (2008) Circ Cardiovasc Qual Outcomes , vol.1 , pp. 29-37
    • Keenan, P.S.1    Normand, S.L.2    Lin, Z.3
  • 17
    • 33645794744 scopus 로고    scopus 로고
    • An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure
    • Krumholz HM, Wang Y, Mattera JA, et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 2006;113:1693-701.
    • (2006) Circulation , vol.113 , pp. 1693-1701
    • Krumholz, H.M.1    Wang, Y.2    Mattera, J.A.3
  • 18
  • 19
    • 0000120995 scopus 로고
    • A class of K-sample tests for comparing the cumulative incidence of a competing risk
    • Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
    • (1988) Ann Stat , vol.16 , pp. 1141-1154
    • Gray, R.J.1
  • 20
    • 79751531393 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2011 update: A report from the American Heart Association
    • Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011;123:e18-e209.
    • (2011) Circulation , vol.123
    • Roger, V.L.1    Go, A.S.2    Lloyd-Jones, D.M.3
  • 22
    • 78650399880 scopus 로고    scopus 로고
    • Eplerenone in patients with systolic heart failure and mild symptoms
    • Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364:11-21.
    • (2011) N Engl J Med , vol.364 , pp. 11-21
    • Zannad, F.1    McMurray, J.J.2    Krum, H.3
  • 23
    • 0032741126 scopus 로고    scopus 로고
    • Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort
    • Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 1948-1955
    • Vasan, R.S.1    Larson, M.G.2    Benjamin, E.J.3
  • 24
    • 77649101171 scopus 로고    scopus 로고
    • Representativeness of a national heart failure quality-of-care registry: Comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients
    • Curtis LH, Greiner MA, Hammill BG, et al. Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients. Circ Cardiovasc Qual Outcomes 2009;2:377-84.
    • (2009) Circ Cardiovasc Qual Outcomes , vol.2 , pp. 377-384
    • Curtis, L.H.1    Greiner, M.A.2    Hammill, B.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.